Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index; 2 of the 16 sources its claims cite were checked for support.
Abstract
The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 3 Not valid · 8 Not checked · 10 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The UKU [57] is an example of a scale that considerably improved the detection of side effects because of its comprehensive nature.”
What the sources say
- Could not verifycites [57] matched to “The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: A meta-analysis of the sequential model and a critical review of the literature” (2016) sourceExperimental — accuracy not yet measured
The Data Synthesis section describes relapse and recurrence as the meta-analysis’s primary outcome, not detection of side effects. Searches for the UKU scale and side-effect detection found no passage in our copy addressing the scale’s comprehensiveness or its effect on detection; the available passages therefore cannot verify the claim. (LLM, conf=0.76)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“the history of toxicology reminds us vividly of the lag that often occurs between the first introduction of a drug into humans and the recognition of certain adverse events from that drug.”
What the sources say
- Could not verifycites [60] matched to “Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial” (2003) sourceExperimental — accuracy not yet measured
The Method and Maintenance of treatment effect sections examine sertraline treatment and outcomes through a one-year follow-up. Searches for delayed recognition of adverse events and drug safety found no passage addressing the interval between a drug’s first use in humans and recognition of its adverse events. The reported deterioration after treatment is not a claim about when adverse events were discovered. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The achievement of such balance is hindered by the varying quality and availability of different sources of information, which lead to a faulty clinical integration.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The assessment of the adverse events is certainly the neglected side of the triangle.”
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“a high correlation does not indicate similar sensitivity.”
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
6 more claims
Create a free account to see all 21 claims and to verify the 14 references still open.
- Probably not a substantial claim. 6
- It may state two separate claims as one. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, trial designs that assess the effects of discontinuing antidepressant drugs for inferring efficacy (i.e., a significant increase in depressive symptoms in the patients whose medications are discontinued and switched to placebo compared to those who continue with treatment) are flawed by lack of consideration and proper assessment of withdrawal events [74].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [74]
Experimental — accuracy not yet measured
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The WHO-5 well-being index: A systematic review of the literature
Topp, C. W., Østergaard, S. D., Søndergaard, S., & Bech, P. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000376585 · Cited by 4,708
Self-citationGarnefski, N., Kraaij, V., Schroevers, M. J., & Somsen, G. A. (2008) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-008-9136-5 · Cited by 2,479
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Self-citationBarlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
The Hopkins Symptom Checklist (HSCL)
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395070 · Cited by 894
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Self-citationMarks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Fava, M., Evins, A. E., Dorer, D. J., & Schoenfeld, D. A. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000069738 · Cited by 452
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citation
Research works printed but not linked: 3
- 2 Bech P: Clinical Psychometrics. Oxford, Wiley-Blackwell, 2012.
- 3 Pichot P: Introduction; in Pichot P (ed): Psychological Measurements in Psychopharmacology. Basel, Karger, 1974, pp 1-7.
- 10 Feinstein AR: Clinimetrics. New Haven, Yale University Press, 1987.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Carrozzino, D., Patierno, C., Fava, G. A., & Guidi, J. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506879 · Cited by 263
Self-citationFava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Self-citationMethodological Recommendations for Trials of Psychological Interventions
Guidi, J., Brakemeier, E.-L., Bockting, C. L. H., Cosci, F., Cuijpers, P., Jarrett, R. B., Linden, M., Marks, I., Peretti, C. S., Rafanelli, C., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000490574 · Cited by 205
Self-citationClinimetric Criteria for Patient-Reported Outcome Measures
Carrozzino, D., Patierno, C., Guidi, J., Berrocal Montiel, C., Cao, J., Charlson, M. E., Christensen, K. S., Concato, J., De las Cuevas, C., de Leon, J., et al. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000516599 · Cited by 177
Self-citationde Leon, J., Ruan, C.-J., Schoretsanitis, G., & De las Cuevas, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000507638 · Cited by 164
Fava, G. A., & Guidi, J. (2020) · World Psychiatry · doi:10.1002/wps.20698 · Cited by 148
Self-citationThe Clinimetric Approach to Psychological Assessment: A Tribute to Per Bech, MD (1942–2018)
Fava, G. A., Carrozzino, D., Lindberg, L., & Tomba, E. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000493746 · Cited by 119
Self-citationDucasse, D., Jaussent, I., Arpon-Brand, V., Vienot, M., Laglaoui, C., Béziat, S., Calati, R., Carrière, I., Guillaume, S., Courtet, P., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488715 · Cited by 103
Herzog, P., Lauff, S., Rief, W., & Brakemeier, E. (2019) · Brain and Behavior · doi:10.1002/brb3.1447 · Cited by 95
Fava, G. A., Guidi, J., Rafanelli, C., & Rickels, K. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480038 · Cited by 93
Self-citationPharmacogenomics: A road ahead for precision medicine in psychiatry
Pardiñas, A. F., Owen, M. J., & Walters, J. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.011 · Cited by 91
The clinical role of well-being therapy
Guidi, J., Rafanelli, C., & Fava, G. A. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1492013 · Cited by 85
“is also a crucial component of patient satisfaction and of perceived change in patients [14,15].”
BackgroundSelf-citationIatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
Self-citationMental Pain as a Transdiagnostic Patient-Reported Outcome Measure
Fava, G. A., Tomba, E., Brakemeier, E.-L., Carrozzino, D., Cosci, F., Eöry, A., Leonardi, T., Schamong, I., & Guidi, J. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000504024 · Cited by 70
Self-citationUnderstanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava, G. A., & Cosci, F. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19com12794 · Cited by 69
Self-citationCarrozzino, D. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109641 · Cited by 66
Benasi, G., Fava, G. A., & Rafanelli, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506110 · Cited by 45
Self-citationFava, G. A. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000520251 · Cited by 46
Self-citationClinimetric Perspectives in Clinical Psychology and Psychiatry
Cosci, F. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000517028 · Cited by 30
Carrozzino, D., Siri, C., & Bech, P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.012 · Cited by 28
Self-citationCosci, F., Chouinard, G., Chouinard, V.-A., & Fava, G. A. (2018) · Rivista di Psichiatria · doi:10.1708/2891.29158 · Cited by 19
Self-citationCorticosteroid-induced manic and/or psychotic symptoms: a systematic review
Gostoli, S., Carrozzino, D., Raimondi, G., Subach, R., Gigante, G., & Rafanelli, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1628765 · Cited by 17
What psychologists need to know about psychotropic medications
Tomba, E., Guidi, J., & Fava, G. A. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2154 · Cited by 11
Self-citationCosci, F., Chouinard, V.-A., & Chouinard, G. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000540031 · Cited by 11
Patacchini, A., & Cosci, F. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001154 · Cited by 10
Pelke, S., Wager, J., Claus, B. B., Stening, K., Zernikow, B., & Reuther, M. (2021) · Children · doi:10.3390/children8100905 · Cited by 10
“This is especially true when treatment effects are expected to be low, and samples are limited [14].”
BackgroundBerwian, I. M., Tröndle, M., de Miquel, C., Ziogas, A., Stefanics, G., Walter, H., Stephan, K. E., & Huys, Q. J. M. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.05.001 · Cited by 10
“The knowledge that a potentially effective medication is being withdrawn may have a nocebo effect, and this may impact realistic clinical settings (46).”
An Evolutionary Approach to Clinical Pharmacopsychology
Rantala, M. J., Luoto, S., & Krams, I. A. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480709 · Cited by 10
The challenge of measurement in psychiatry: the lifetime accomplishments of Per Bech (1942-2018)
Fleck, M. P. D. A., Carrozzino, D., & Fava, G. A. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0509 · Cited by 10
Self-citationThe Emerging Role of Clinical Pharmacopsychology
Cosci, F., Guidi, J., Tomba, E., & Fava, G. A. (2019) · Clinical Psychology in Europe · doi:10.32872/cpe.v1i2.32158 · Cited by 9
Self-citationHui, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243057 · Cited by 8
“Some have argued that contributing to this problem is an overreliance of psychopharmacologic research on psychometrics that rely excessively on symptom lists derived from diagnostic criteria [8].”
BackgroundOvercoming the Crisis of Clinical Research
Fava, G. A., Cosci, F., & Tomba, E. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000485001 · Cited by 8
Self-citationPromoting safer and wider worldwide use of clozapine
de León, J. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.03.003 · Cited by 7
Cuevas, C. D. L., & de León, J. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000495940 · Cited by 7
A pharmacopsychometric overview of major depressive episodes in positive psychiatry
Bech, P., Vernooij-Dassen, M. J. F. J., Moniz-Cook, E. D., & Jeon, Y. (2018) · International Psychogeriatrics · doi:10.1017/s1041610217003015 · Cited by 5
“The combination of psychopharmacology and psychotherapy in unipolar depression seems actually to follow the reciprocation model (Fava et al., 2017), i.”
BackgroundSelf-citationThe clinical consequence of positive mental health in psychotherapy
Fulcheri, M., & Carrozzino, D. (2017) · Research in Psychotherapy Psychopathology Process and Outcome · doi:10.4081/ripppo.2017.280 · Cited by 5
“Nowadays, we have a lot of empirical data evidencing that equating the presence of a mental health condition with the mere absence of psychopathological symptoms consists of a diagnostically inadequate method and clinically reductionistic viewpoint (Fava et al., 2017).”
BackgroundMethodInfluentialFava, G. A., Cosci, F., Montiel, C. B., & Tomba, E. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000495967 · Cited by 4
Self-citationIndication is Key to Prevent Inverse Care
Beeker, T., & Pišl, V. (2026) · The American Journal of Bioethics · doi:10.1080/15265161.2025.2608632 · Cited by 3
“…severity (Kirsch et al. 2008), (b) potentially harmful to everyone because of side effects and adverse reactions (Pillinger et al. 2023), (c) much more difficult to discontinue than thought for a long time (Horowitz et al. 2023), and (d) quite often worsening long term outcomes (Fava et al. 2017).”
Berwian, I. M., Tröndle, M., Miquel, C. D., Ziogas, A., Stefanics, G., Walter, H., Stephan, K. E., & Huys, Q. J. M. (2023) · doi:10.1101/2023.07.05.547831 · Cited by 2
Fava, G. A., & Guidi, J. (2020) · Ärztliche Psychotherapie · doi:10.21706/aep-15-3-149 · Cited by 1
Self-citationUse of Hericium erinaceus as a potential therapeutic of mental disorders: a systematic review
Cortonesi, P. M. M., de Almeida, L. F., Pinheiro, R. M. T., Périco, C. D. A.-M., & Castaldelli-Maia, J. M. (2023) · Debates em Psiquiatria · doi:10.25118/2763-9037.2023.v13.443 · Cited by 1
Pharmacogenetic Factors in Pharmacodynamic/Pharmacokinetic (PD/PK) Modulations of Medicines
Yerer, M. B. (2023) · Springer eBooks · doi:10.1007/978-981-99-1529-3_6 · Cited by 1
Cuevas, C. D. L., & de León, J. (2025) · Motivation Science · doi:10.1037/mot0000321 · Cited by 1
Response to “An Evolutionary Approach to Clinical Pharmacopsychology”
Bech, P., Tomba, E., & Fava, G. A. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000481100
Self-citationFatoye, C., Betts, A., Odeyemi, A., Fatoye, F., & Odeyemi, I. (2020) · Mediterranean Journal of Clinical Psychology · doi:10.6092/2282-1619/mjcp-2363
Stein, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00209-0
O ensino da psicofarmacologia na formação inicial dos psicólogos portugueses: Estado da arte
Leite, A. B., da Silva, C. F., Pereira, A., & Marques, D. R. (2023) · Psychologica · doi:10.14195/1647-8606_65_7
Le contexte de l’arrêt guidé des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00006-6
Self-citationLa décision d’arrêter de prendre des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00005-4
Self-citationFava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00007-8
Self-citationChapter 4. The Myth of Treatment Resistance?
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551937.lg04
Leone, F. D., Fransson, J., Sundquist, M., Strand, J., Liljedahl, S., & Sand, P. K. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1850502
Monteiro, F. L. F., & da Silva, A. J. D. S. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i11.9331
Metadata
- Authors
- Fava, G. A., Tomba, E., & Bech, P.
- Affiliations
- University of Bologna (IT)
- Copenhagen University Hospital (DK)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 86
- Issue
- 3
- Pages
- 134-140
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2613087407
- Semantic Scholar
- 9566edfc2f854e96b5dd99691a6b765940a319de
- Cited by
- 52
- References
- 76
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 4 · 2021: 6 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 5
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Keywords
- psychotropic drugs, adverse drug reactions, behavioral toxicity, treatment response, clinimetrics, quality of life, well-being
- MeSH terms
- Mental Disorders, Humans, Psychopharmacology, Psychotherapy, Psychotropic Drugs, Quality of Life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.